1.
Baena Cañada JM, de la Torre Hita C, Bernal Gómez M, Campini Bermejo A, Gámez Casado S, Rodríguez Pérez L, et al. Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study. Arch Breast Cancer [Internet]. 2021 Jul. 27 [cited 2026 Jan. 12];:233-42. Available from: https://archbreastcancer.com/index.php/abc/article/view/409